Trials / Completed
CompletedNCT02473666
Patient Blood Management - Use and Outcome
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 250,000 (actual)
- Sponsor
- University of Zurich · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Study the influence of transfusion related Patient Blood Management Program actions on transfusion-related outcome measures and cost.
Detailed description
At the University Hospital of Zurich, an in-house designed monitoring and feedback system was introduced which electronically registers each transfusion of any allogeneic blood product, be it red blood cells, plasma or platelets as well as corresponding laboratory data. Results are reported quarterly to Department heads. The investigator analyzes whether the introduction of this monitoring and feedback system as part of a patient blood management Program has a significant influence on use of allogeneic blood product transfusions and transfusion-related costs, without compromising patient outcome.
Conditions
Timeline
- Start date
- 2012-01-01
- Primary completion
- 2019-12-01
- Completion
- 2019-12-01
- First posted
- 2015-06-16
- Last updated
- 2020-11-12
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT02473666. Inclusion in this directory is not an endorsement.